These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9808859)

  • 1. A randomized, double-blind, placebo-controlled, crossover study to assess the immediate effect of sublingual glyceryl trinitrate on the ankle brachial pressure index, claudication, and maximum walking distance of patients with intermittent claudication.
    Walker SR; Tennant S; MacSweeney ST
    J Vasc Surg; 1998 Nov; 28(5):895-900. PubMed ID: 9808859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R; Walker S; MacSweeney S
    Curr Med Res Opin; 2001; 17(2):113-5. PubMed ID: 11759179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular surgical society of great britain and ireland: prospective randomized double-blind placebo-controlled crossover study to assess the effect of sublingual glyceryl trinitrate in patients with intermittent claudication.
    Walker SR; Heer R; MacSweeney ST
    Br J Surg; 1999 May; 86(5):694. PubMed ID: 10361320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent Administration of Nitroglycerin Sublingual Powder Compared with Placebo in Outpatients with Peripheral Artery Disease: Results of a Randomised Proof of Concept Study.
    Lawall H; Bramlage P; Gorath M; Wittig T
    Eur J Vasc Endovasc Surg; 2021 Mar; 61(3):457-465. PubMed ID: 33358350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT; Nicolaides AN; Wolfe JH; Stansby G
    J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of walking distance on the change in ankle-brachial pressure index in patients with intermittent claudication.
    Sakurai T; Matsushita M; Nishikimi N; Nimura Y
    Eur J Vasc Endovasc Surg; 1997 May; 13(5):486-90. PubMed ID: 9166272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication.
    Shahin Y; Barnes R; Barakat H; Chetter IC
    Atherosclerosis; 2013 Dec; 231(2):283-90. PubMed ID: 24267241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buflomedil for intermittent claudication.
    De Backer TL; Vander Stichele RH; Bogaert MG
    Cochrane Database Syst Rev; 2001; (1):CD000988. PubMed ID: 11279700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL; Cutler BS; Meissner MH; Strandness DE
    Circulation; 1998 Aug; 98(7):678-86. PubMed ID: 9715861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cilostazol on resting ankle pressures and exercise-induced ischemia in patients with intermittent claudication.
    Mohler ER; Beebe HG; Salles-Cuhna S; Zimet R; Zhang P; Heckman J; Forbes WP
    Vasc Med; 2001; 6(3):151-6. PubMed ID: 11789969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of treatment with intermittent negative pressure for intermittent claudication.
    Hoel H; Pettersen EM; Høiseth LØ; Mathiesen I; Seternes A; Hisdal J
    J Vasc Surg; 2021 May; 73(5):1750-1758.e1. PubMed ID: 33899743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term study of policosanol in the treatment of intermittent claudication.
    Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
    Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
    Money SR; Herd JA; Isaacsohn JL; Davidson M; Cutler B; Heckman J; Forbes WP
    J Vasc Surg; 1998 Feb; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supervised exercise training for intermittent claudication: lasting benefit at three years.
    Ratliff DA; Puttick M; Libertiny G; Hicks RC; Earby LE; Richards T
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):322-6. PubMed ID: 17587612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
    Regensteiner JG; Ware JE; McCarthy WJ; Zhang P; Forbes WP; Heckman J; Hiatt WR
    J Am Geriatr Soc; 2002 Dec; 50(12):1939-46. PubMed ID: 12473004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
    Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group.
    Lièvre M; Morand S; Besse B; Fiessinger JN; Boissel JP
    Circulation; 2000 Jul; 102(4):426-31. PubMed ID: 10908215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
    Mangiafico RA; Messina R; Attinà T; Dell'Arte S; Giuliano L; Malatino LS
    Angiology; 2000 Jun; 51(6):441-9. PubMed ID: 10870853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent claudication: exercise-increased walking distance is not related to improved cardiopulmonary fitness.
    Ng PW; Hollingsworth SJ; Luery H; Kumana TJ; Chaloner EJ
    Eur J Vasc Endovasc Surg; 2005 Oct; 30(4):391-4. PubMed ID: 15963739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
    Mohler ER; Hiatt WR; Olin JW; Wade M; Jeffs R; Hirsch AT
    J Am Coll Cardiol; 2003 May; 41(10):1679-86. PubMed ID: 12767646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.